CVS Health (CVS) Tops Q2 EPS by 10c; cuts profit guidance
Tweet
Share
E-mail
Get Alerts CVS Hot Sheet
Price: $103.45 -0.13%
EPS Growth %: +1.1%
Financial Fact:
Net income: 1.54B
Today's EPS Names:
DTGI, CRMT, STZ, More
EPS Growth %: +1.1%
Financial Fact:
Net income: 1.54B
Today's EPS Names:
DTGI, CRMT, STZ, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q2 EPS of $1.83, $0.10 better than the analyst estimate of $1.73. Revenue for the quarter came in at $91.2 billion versus the consensus estimate of $91.43 billion.
GUIDANCE:
CVS Health sees FY2024 EPS of $6.40-$6.65, versus the consensus of $6.97.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump Bought At Least $100,001 In Palantir Shares, Disclosure Shows - Bloomberg
- NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
- Allison Transmission to Join S&P MidCap 400; Goodyear Tire & Rubber to Join S&P SmallCap 600
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
